Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05319015
Title Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.